Exabis Library
Welcome to the e-CCO Library!
DOP33 Stratification of patients for treatment with adalimumab by a combination of immune-profiling and in vivo efficacy studies in a novel mouse model of ulcerative colitis
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
DOP33: Distinct perturbances in metabolic pathways associate with disease progression in patients with Inflammatory Bowel Disease
2024
ECCO'24 Stockholm
Tuesday, 30 April 2024, 5:03 PM
DOP33: Long-term clinical efficacy of ustekinumab in refractory Crohn’s disease : a multi-centre Belgian cohort study
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
DOP33: Long-term clinical efficacy of ustekinumab in refractory Crohn’s disease : a multi-centre Belgian cohort study
2019
ECCO'19 Copenhagen
Tuesday, 28 May 2019, 3:32 PM
1
DOP33: Predictors of ileo-rectal anastomosis, permanent ileostomy and recurrence of disease after total colectomy for Crohn’s Colitis: Results over 20 years
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
DOP33: Role of adherent and invasive E. coli in Crohn’s Disease: Lessons from the postoperative recurrence model
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
DOP33: Single-cell analysis identifies pathological fibroblasts as a new therapeutic target to prevent intestinal fibrosis in Crohn's disease.
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:43 AM
DOP33: Single-cell analysis identifies pathological fibroblasts as a new therapeutic target to prevent intestinal fibrosis in Crohn’s disease.
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 2:22 PM
DOP33: Stratification of patients for treatment with adalimumab by a combination of immune-profiling and in vivo efficacy studies in a novel mouse model of Ulcerative Colitis
2020
ECCO'20 Vienna
Tuesday, 23 June 2020, 4:58 PM
1
DOP34 Transplantation of human intestine into the mouse: A novel platform for study of inflammatory enterocutaneous fistulas
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
DOP34: Comparison of the risk of clinical recurrence after ileocolonic resection for Crohn's Disease for modified Rutgeerts' score i2a and i2b categories: Individual patient data meta-analysis
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
DOP34: Deciphering immune-epithelial interactions in health and in Inflammatory Bowel Disease
2024
ECCO'24 Stockholm
Tuesday, 30 April 2024, 5:03 PM
DOP34: Disease activity patterns during the first 5 years after diagnosis in children with ulcerative colitis: a population-based study
2019
ECCO'19 Copenhagen
Tuesday, 28 May 2019, 3:32 PM
1
DOP34: Disease activity patterns during the first 5 years after diagnosis in children with ulcerative colitis: a population-based study
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
DOP34: Human MD2 deficiency - an inborn error of immunity predisposing to early onset Inflammatory Bowel Disease
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 2:22 PM
DOP34: Human MD2 deficiency - an inborn error of immunity predisposing to early onset Inflammatory Bowel Disease
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:43 AM
DOP34: Long-term outcome of Acute Severe Ulcerative Colitis responsive to intravenous steroid: A multicenter study of the Italian Group for the study of Inflammatory Bowel Disease (IG-IBD)
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
DOP34: Transplantation of human intestine into the mouse: A novel platform for study of inflammatory enterocutaneous fistulas
2020
ECCO'20 Vienna
Tuesday, 23 June 2020, 4:58 PM
1
DOP35 Monitoring of mucosal T cells subsets under biotherapies in IBD: responders exhibit a phenotype similar to healthy controls
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
DOP35: Ambulatory care management of 70 patients with Acute Severe Ulcerative Colitis in comparison to 700 inpatients: Insights from a multicentre UK cohort study
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM